J9144 HCPCS code: Injection, daratumumab, 10 mg and hyaluronidase-fihj
J9144 is the HCPCS Level II code for injection, daratumumab, 10 mg and hyaluronidase-fihj. In 2024 Medicare paid an average of $38.87 per service for J9144 across 18,925,033 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 180 per day on outpatient hospital claims. Medicare volume rose 48% from 2022 to 2024 (12,798,653 to 18,925,033 services). In 2024, about 4,094 clinicians billed Medicare for J9144 for 10,191 beneficiaries; Florida, California, Texas accounted for 31% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1D — Chemotherapy |
| Added | 2021-01-01 |
| Last action effective | 2021-01-01 |
Who bills J9144 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 4,094 |
| Medicare beneficiaries | 10,191 |
| States with claims | 47 |
| Share of services in top 3 states (Florida, California, Texas) | 31% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J9144, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 12,798,653 | 6,897 | $45.02 | $35.94 |
| 2023 | 16,249,735 | 8,689 | $47.22 | $37.61 |
| 2024 | 18,925,033 | 10,191 | $48.81 | $38.87 |
States with the most J9144 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Florida | 2,204,423 | $38.93 |
| California | 2,132,675 | $39.05 |
| Texas | 1,559,701 | $38.94 |
| Illinois | 979,209 | $38.97 |
| Virginia | 972,900 | $39.11 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 180 | Prescribing Information |
| practitioner claims | 180 | Prescribing Information |
What changed for J9144
- 2021-01-01: J9144 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J9144?
J9144 is the HCPCS Level II code for injection, daratumumab, 10 mg and hyaluronidase-fihj. Short descriptor: "Daratumumab, hyaluronidase".
How much does Medicare pay for J9144?
In 2024, the average Medicare payment was $38.87 per service (average allowed $48.81).
Does Medicare cover J9144?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J9144 can be billed per day?
180 on outpatient hospital claims; 180 on practitioner claims (NCCI medically unlikely edits).
Related J91 codes
- J9100 — Injection, cytarabine, 100 mg
- J9118 — Injection, calaspargase pegol-mknl, 10 units
- J9119 — Injection, cemiplimab-rwlc, 1 mg
- J9120 — Injection, dactinomycin, 0.5 mg
- J9130 — Dacarbazine, 100 mg
- J9145 — Injection, daratumumab, 10 mg
- J9150 — Injection, daunorubicin, 10 mg
- J9151 — Injection, daunorubicin citrate, liposomal formulation, 10 mg
- J9153 — Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine
- J9155 — Injection, degarelix, 1 mg
- J9160 — Injection, denileukin diftitox, 300 micrograms
- J9161 — Injection, denileukin diftitox-cxdl, 1 mcg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J9144
- Watch J9144 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J9144
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.